News Sentiment

LMAT sentiment intelligence

LeMaitre Vascular Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 58 Balanced news tone 45 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Medical Instruments & Supplies Read-through group
Latest close 102.74 Week of 10 Jul 2026
Weighted tone 58/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

74/100 classification confidence.

Company focus 45

directly relevant articles

Source quality 1

high-authority source matches

Trend context Trend active

-0.1% over one week, +11.7% over four weeks, trend active, and materially above fair value.

Latest direct headline Neutral

LeMaitre Vascular to Report Second Quarter 2026 Financial Results on August 4

Market Reaction

Balanced read

56/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 74/100 classification
One-week reaction -0.1% Price digesting
Trend fit Trend active 11.7% over four weeks
Fair value 26.8% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 20
Neutral 23
Negative 2

Relevance

Why the article matched

Direct first
Direct company coverage 45
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
MarketBeat 12
TradingView 7
Market source 6
TradingKey 4
Quiver Quantitative 2
Stock Titan 2
Finviz 2
simplywall.st 2

Event Lens

What the news is about

Classified themes
Earnings 18
Market update 18
Analyst action 6
Capital return 2
Guidance 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 45
The Manila Times Direct company coverage

LeMaitre Will Announce Second Quarter 2026 Earnings Results on August 4, 2026

LeMaitre Vascular, Inc. announced it will release its second quarter 2026 financial results on Tuesday, August 4, 2026, after market close. The company will host a conference call at 5:00 PM EDT on the same day to discuss the results and outlook. Interested parties can register o

Tone
Neutral 50/100
Event
Earnings
Published
14 Jul 2026 22:15
Source
The Manila Times
Stock Titan Direct company coverage

LeMaitre Schedules Aug. 4 Call to Discuss Second-Quarter Results

LeMaitre (Nasdaq: LMAT) will release its second-quarter 2026 financial results on Tuesday, August 4, 2026, after the market close. The company will host a conference call at 5:00 PM EDT on the same day to review business highlights and outlook. Investors can register online for d

Tone
Neutral 50/100
Event
Earnings
Published
14 Jul 2026 21:15
Source
Stock Titan
MarketBeat Direct company coverage

LeMaitre Vascular (NASDAQ:LMAT) Cut to "Hold" at Zacks Research

Zacks Research downgraded LeMaitre Vascular (NASDAQ:LMAT) from "strong-buy" to "hold" despite a mixed to positive broader analyst view and a consensus "Moderate Buy" rating with a target price of $112.60. The company's stock was up 1.9% at market open, nearing its 52-week high, a

Tone
Positive 61/100
Event
Analyst action
Published
08 Jul 2026 10:40
Source
MarketBeat
MarketBeat Direct company coverage

LeMaitre Vascular, Inc. (NASDAQ:LMAT) Receives Consensus Recommendation of "Moderate Buy" from Analysts

LeMaitre Vascular, Inc. (NASDAQ:LMAT) has received a consensus "Moderate Buy" rating from analysts, with an average 12-month price target of $112.60. The company recently reported strong quarterly results, beating earnings estimates with $0.68 per share and an 11.1% revenue incre

Tone
Positive 66/100
Event
Earnings
Published
07 Jul 2026 16:11
Source
MarketBeat
MarketBeat Direct company coverage

LeMaitre Vascular (NASDAQ:LMAT) Upgraded to "Buy" at Wall Street Zen

LeMaitre Vascular (NASDAQ:LMAT) received an upgrade from "hold" to "buy" by Wall Street Zen, contributing to a "Moderate Buy" consensus rating among analysts with a target price of $112.60. The company reported strong financial results, beating EPS estimates and showing an 11.1%

Tone
Positive 76/100
Event
Analyst action
Published
04 Jul 2026 05:40
Source
MarketBeat
MarketBeat Direct company coverage

LeMaitre Vascular, Inc. $LMAT is Conestoga Capital Advisors LLC's 7th Largest Position

Conestoga Capital Advisors LLC increased its stake in LeMaitre Vascular (LMAT) by 3.6% in the first quarter, making it their 7th largest holding. LeMaitre Vascular reported strong quarterly earnings of $0.68 per share and an 11.1% increase in revenue. Despite mixed Wall Street vi

Tone
Positive 65/100
Event
Earnings
Published
02 Jul 2026 08:12
Source
MarketBeat
TradingView Direct company coverage

LeMaitre Vascular, Inc. Financial Disclosures & Filings

This page provides access to LeMaitre Vascular, Inc.'s financial disclosures and regulatory filings, including quarterly and annual earnings reports, 8-K forms, 10-Q and 10-K reports, and investor presentations. The documents span from 2021 through Q1 FY2026, offering insights in

Tone
Positive 94/100
Event
Earnings
Published
01 Jul 2026 18:40
Source
TradingView
Finviz Direct company coverage

LMAT - Lemaitre Vascular Inc Latest SEC Filings

This article provides a detailed financial overview and recent SEC filing information for Lemaitre Vascular Inc (LMAT). It includes current stock performance metrics, key financial ratios, insider and institutional ownership data, and various performance indicators across differe

Tone
Positive 63/100
Event
Market update
Published
01 Jul 2026 11:40
Source
Finviz
MarketBeat Direct company coverage

LeMaitre Vascular, Inc. $LMAT Shares Sold by SG Americas Securities LLC

SG Americas Securities LLC significantly reduced its stake in LeMaitre Vascular, Inc. by 51.3% in the first quarter, now holding 27,204 shares valued at $2.97 million. This comes as LeMaitre Vascular reported better-than-expected quarterly earnings and an 11.1% increase in revenu

Tone
Neutral 50/100
Event
Earnings
Published
01 Jul 2026 08:39
Source
MarketBeat
TradingView Direct company coverage

Price to book forward of LeMaitre Vascular, Inc. – NASDAQ:LMAT

The article focuses on the "Price to book forward" metric for LeMaitre Vascular, Inc., traded on NASDAQ under the symbol LMAT. It primarily presents the company's financial overview within the TradingView platform, noting that the market was closed at the time of access. The cont

Tone
Neutral 50/100
Event
Market update
Published
28 Jun 2026 04:09
Source
TradingView
TradingView Direct company coverage

LeMaitre Vascular, Inc. Actuals & Estimates (NASDAQ:LMAT)

This article provides an overview of LeMaitre Vascular, Inc. (NASDAQ: LMAT) stock, including its current price, performance, and analyst forecasts. It also details financial information such as market capitalization, earnings, revenue, dividends, and employee count, alongside tec

Tone
Positive 76/100
Event
Earnings
Published
27 Jun 2026 15:40
Source
TradingView
TradingView Direct company coverage

Price to sales forward of LeMaitre Vascular, Inc. – NASDAQ:LMAT

This article provides financial information for LeMaitre Vascular, Inc. (NASDAQ: LMAT), specifically focusing on its forward price to sales ratio. It lists the company on the Nasdaq Stock Market and appears to be a stub or placeholder from TradingView, indicating that detailed fi

Tone
Neutral 50/100
Event
Market update
Published
27 Jun 2026 00:39
Source
TradingView
TradingView Direct company coverage

LeMaitre Vascular, Inc. Actuals & Estimates (SWB:LHU)

This article provides actuals and estimates for LeMaitre Vascular, Inc. (SWB:LHU), including financial data, analyst forecasts, and common stock information. It details the company's past earnings, revenue, net income, dividends, and offers insights into its stock performance and

Tone
Neutral 50/100
Event
Earnings
Published
26 Jun 2026 18:11
Source
TradingView
TradingKey Direct company coverage

LeMaitre Vascular Inc (LMAT) Institutional Confidence

LeMaitre Vascular Inc (LMAT) has an institutional shareholding score of 10.00, placing it first in the Healthcare Equipment & Supplies industry. Institutional shareholding increased by 8.41% quarter-over-quarter, reaching 102.98%. The largest institutional holder is ETHSX with 27

Tone
Positive 70/100
Event
Market update
Published
26 Jun 2026 08:10
Source
TradingKey
TradingView Direct company coverage

LMAT Forecast — Price Target — Prediction for 2027

This article provides a forecast for LeMaitre Vascular, Inc. (LMAT) stock, including its current price, analyst ratings, and financial data. It details the company's price target, EPS, revenue, and dividend information, along with offering answers to frequently asked questions ab

Tone
Positive 60/100
Event
Earnings
Published
26 Jun 2026 05:11
Source
TradingView
TradingView Direct company coverage

LeMaitre Vascular, Inc. Actuals & Estimates (TRADEGATE:LHU)

This article provides an overview of LeMaitre Vascular, Inc. (TRADEGATE:LHU) stock, including historical data, analyst forecasts, and financial performance. It covers details like price targets, earnings reports, revenue, net income, dividends, EBITDA, and employee numbers, along

Tone
Neutral 50/100
Event
Earnings
Published
26 Jun 2026 01:10
Source
TradingView
MarketBeat Direct company coverage

Rockefeller Capital Management L.P. Sells 100,923 Shares of LeMaitre Vascular, Inc. $LMAT

Rockefeller Capital Management L.P. significantly reduced its stake in LeMaitre Vascular, Inc. by selling 100,923 shares, decreasing its holdings by 37.9% in the fourth quarter. Despite this, LeMaitre Vascular reported strong quarterly earnings, exceeding analyst expectations wit

Tone
Positive 59/100
Event
Earnings
Published
25 Jun 2026 08:40
Source
MarketBeat
MarketBeat Direct company coverage

Riverbridge Partners LLC Buys Shares of 105,599 LeMaitre Vascular, Inc. $LMAT

Riverbridge Partners LLC initiated a new position in LeMaitre Vascular, Inc., acquiring 105,599 shares valued at approximately $11.5 million in the first quarter of 2026. This investment makes Riverbridge Partners LLC one of several institutional investors increasing their stakes

Tone
Positive 71/100
Event
Earnings
Published
24 Jun 2026 10:22
Source
MarketBeat
MarketBeat Direct company coverage

LeMaitre Vascular (NASDAQ:LMAT) Rating Lowered to Hold at Wall Street Zen

Wall Street Zen downgraded LeMaitre Vascular (NASDAQ:LMAT) from a "buy" to a "hold" rating, despite the broader analyst consensus remaining a "Moderate Buy" with an average price target of $112.60. The company recently exceeded earnings expectations with $0.68 EPS and an 11.1% in

Tone
Neutral 50/100
Event
Analyst action
Published
20 Jun 2026 05:40
Source
MarketBeat
TradingKey Direct company coverage

LeMaitre Vascular Inc (LMAT) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for LeMaitre Vascular Inc (LMAT), highlighting its current earnings forecast score of 7.80, which ranks 120th in the Healthcare Equipment & Supplies industry. Analysts have set an average price target of $108.00 for LMAT, with most recom

Tone
Neutral 50/100
Event
Earnings
Published
18 Jun 2026 07:09
Source
TradingKey
TradingKey Direct company coverage

LeMaitre Vascular Inc (LMAT) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of LeMaitre Vascular Inc (LMAT), detailing its price momentum score, current trading range, and technical indicator readings. It highlights that LMAT's price momentum score is 6.67, trading between a resistance level of 99.82 and a suppo

Tone
Negative 39/100
Event
Market update
Published
18 Jun 2026 06:41
Source
TradingKey
TradingKey Direct company coverage

LeMaitre Vascular Inc (LMAT) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article provides a revenue breakdown for LeMaitre Vascular Inc (LMAT), focusing on its regional revenue contributions. As of a recent update, the United States accounted for 56.72% of its revenue, followed by Other countries, Germany, Canada, and the United Kingdom. The comp

Tone
Neutral 50/100
Event
Earnings
Published
18 Jun 2026 01:41
Source
TradingKey
Stock Traders Daily Direct company coverage

(LMAT) Volatility Zones as Tactical Triggers

This article analyzes Lemaitre Vascular Inc. (NASDAQ: LMAT), highlighting weak near and mid-term sentiment but a strong long-term positive outlook. It identifies key support and resistance levels, offering three distinct AI-generated trading strategies: Position Trading, Momentum

Tone
Negative 39/100
Event
Guidance
Published
16 Jun 2026 13:10
Source
Stock Traders Daily
MarketBeat Direct company coverage

Kennedy Capital Management LLC Has $20.11 Million Stock Position in LeMaitre Vascular, Inc. $LMAT

Kennedy Capital Management LLC increased its stake in LeMaitre Vascular, Inc. (NASDAQ:LMAT) by 14.8% during the fourth quarter, now holding 247,907 shares valued at $20.1 million. Despite insider selling totaling 54,453 shares worth $5.9 million, analysts generally maintain a "Mo

Tone
Positive 62/100
Event
Earnings
Published
14 Jun 2026 10:38
Source
MarketBeat
MSN Direct company coverage

LeMaitre Vascular declares $0.25 dividend

LeMaitre Vascular has declared a quarterly dividend of $0.25 per share.

Tone
Positive 68/100
Event
Capital return
Published
12 Jun 2026 19:38
Source
MSN
MarketBeat Direct company coverage

LeMaitre Vascular, Inc. (NASDAQ:LMAT) Given Consensus Recommendation of "Moderate Buy" by Brokerages

LeMaitre Vascular, Inc. (NASDAQ:LMAT) has received a "Moderate Buy" consensus rating from eight brokerages, with an average 12-month price target of $112.60, driven by positive analyst sentiment and solid Q1 earnings that surpassed estimates. Despite recent insider selling, the c

Tone
Positive 66/100
Event
Analyst action
Published
12 Jun 2026 08:40
Source
MarketBeat